ClinicalTrials.Veeva

Menu

Comparison of the Pentax AWS® With the Macintosh Laryngoscopic Intubation in Obstructive Sleep Apnea Syndrome Patients

K

Kyung Hee University

Status and phase

Unknown
Phase 4

Conditions

Sleep Apnea, Obstructive

Treatments

Device: Pentax-AWS (AWS; Pentax Corporation, Tokyo, Japan)

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The Pentax-AWS_ system (AWS; Pentax Corporation, Tokyo, Japan) is a new rigid indirect laryngoscope which has an integrated tube passage function. Pentax-AWS improved the laryngeal view and facilitated tracheal intubation in patients with restricted neck motion. The purpose of this clinical trial was to evaluate the relative efficacy of the AWS laryngoscopes when used by experienced anesthetists in Obstructive Sleep Apnea Syndrome (OSAS) patients and to compare its performance with the Macintosh laryngoscope.

Full description

The occurrence of difficult intubation in OSAS patients is higher than in age and sex matched control patients. The Pentax-AWS_ system (AWS; Pentax Corporation, Tokyo, Japan) is a new rigid indirect laryngoscope which has an integrated tube passage function. Several studies reported that Pentax-AWS improved the laryngeal view and guide also facilitated rapid, easy and reliable tracheal intubation in patients undergoing elective surgery. The purpose of this clinical trial was to evaluate the relative efficacy of the AWS laryngoscopes when used by experienced anesthetists in OSAS patients and to compare its performance with the Macintosh laryngoscope. The investigators hypothesized that, in comparison with the Macintosh, AWS would reduce intubation difficulty, as measured by the intubation difficulty scale (IDS) score.

Enrollment

50 estimated patients

Sex

All

Ages

20 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • ASA physical status 1-3 patients,
  • aged 20years or older,
  • undergoing uvulopalatopharyngoplasty(UPPP) surgery under general anesthesia for a polysomnography-confirmed diagnosis of OSAS.

Exclusion criteria

  • unstable teeth or mouth opening of < 18mm
  • Patients with any pathology of the neck,
  • upper respiratory tract or upper alimentary tracts,
  • risk of pulmonary aspiration of gastric contents,
  • a history of relevant drug allergy.

Trial design

50 participants in 2 patient groups

Pentax-AWS
Experimental group
Description:
Patients in this group will be intubated using Pentax-AWS
Treatment:
Device: Pentax-AWS (AWS; Pentax Corporation, Tokyo, Japan)
laryngoscopy
Active Comparator group
Description:
Patients in this group will be intubated using Macintosh laryngoscope.
Treatment:
Device: Pentax-AWS (AWS; Pentax Corporation, Tokyo, Japan)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems